655 related articles for article (PubMed ID: 29950523)
41. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
[TBL] [Abstract][Full Text] [Related]
42. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
Yoon JC; Puigserver P; Chen G; Donovan J; Wu Z; Rhee J; Adelmant G; Stafford J; Kahn CR; Granner DK; Newgard CB; Spiegelman BM
Nature; 2001 Sep; 413(6852):131-8. PubMed ID: 11557972
[TBL] [Abstract][Full Text] [Related]
43. miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α.
Fang Z; Li P; Jia W; Jiang T; Wang Z; Xiang Y
Int J Mol Med; 2016 Sep; 38(3):845-52. PubMed ID: 27432632
[TBL] [Abstract][Full Text] [Related]
44. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.
Han HS; Jung CY; Yoon YS; Choi S; Choi D; Kang G; Park KG; Kim ST; Koo SH
Sci Signal; 2014 Feb; 7(314):ra19. PubMed ID: 24570487
[TBL] [Abstract][Full Text] [Related]
45. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.
Liang H; Balas B; Tantiwong P; Dube J; Goodpaster BH; O'Doherty RM; DeFronzo RA; Richardson A; Musi N; Ward WF
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E945-54. PubMed ID: 19208857
[TBL] [Abstract][Full Text] [Related]
46. HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter.
Xu X; Shi X; Chen Y; Zhou T; Wang J; Xu X; Chen L; Hu L; Shen X
Metabolism; 2018 Aug; 85():126-138. PubMed ID: 29577938
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of human selenoprotein H in neuronal cells enhances mitochondrial biogenesis and function through activation of protein kinase A, protein kinase B, and cyclic adenosine monophosphate response element-binding protein pathway.
Mehta SL; Mendelev N; Kumari S; Andy Li P
Int J Biochem Cell Biol; 2013 Mar; 45(3):604-11. PubMed ID: 23220172
[TBL] [Abstract][Full Text] [Related]
48. PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism.
Lee J; Salazar Hernández MA; Auen T; Mucka P; Lee J; Ozcan U
Mol Metab; 2018 Jan; 7():119-131. PubMed ID: 29129613
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional corepressor SMILE recruits SIRT1 to inhibit nuclear receptor estrogen receptor-related receptor gamma transactivation.
Xie YB; Park JH; Kim DK; Hwang JH; Oh S; Park SB; Shong M; Lee IK; Choi HS
J Biol Chem; 2009 Oct; 284(42):28762-74. PubMed ID: 19690166
[TBL] [Abstract][Full Text] [Related]
50. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Seo HY; Kim MK; Min AK; Kim HS; Ryu SY; Kim NK; Lee KM; Kim HJ; Choi HS; Lee KU; Park KG; Lee IK
Endocrinology; 2010 Feb; 151(2):561-8. PubMed ID: 20022930
[TBL] [Abstract][Full Text] [Related]
51. Dietary iron modulates hepatic glucose homeostasis via regulating gluconeogenesis.
Li J; Jia L; Ma W; Feng Y; Yu H; Du H
J Nutr Biochem; 2022 Nov; 109():109104. PubMed ID: 35863586
[TBL] [Abstract][Full Text] [Related]
52. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
Hogan MF; Ravnskjaer K; Matsumura S; Huising MO; Hull RL; Kahn SE; Montminy M
J Biol Chem; 2015 Oct; 290(43):25997-6006. PubMed ID: 26342077
[TBL] [Abstract][Full Text] [Related]
53. FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway.
Potthoff MJ; Boney-Montoya J; Choi M; He T; Sunny NE; Satapati S; Suino-Powell K; Xu HE; Gerard RD; Finck BN; Burgess SC; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2011 Jun; 13(6):729-38. PubMed ID: 21641554
[TBL] [Abstract][Full Text] [Related]
54. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Park JE; Han JS
Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
[TBL] [Abstract][Full Text] [Related]
55. Interaction of CREB and PGC-1α Induces Fibronectin Type III Domain-Containing Protein 5 Expression in C2C12 Myotubes.
Yang XY; Tse MCL; Hu X; Jia WH; Du GH; Chan CB
Cell Physiol Biochem; 2018; 50(4):1574-1584. PubMed ID: 30359971
[TBL] [Abstract][Full Text] [Related]
56. SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes.
Yamamoto T; Shimano H; Nakagawa Y; Ide T; Yahagi N; Matsuzaka T; Nakakuki M; Takahashi A; Suzuki H; Sone H; Toyoshima H; Sato R; Yamada N
J Biol Chem; 2004 Mar; 279(13):12027-35. PubMed ID: 14722127
[TBL] [Abstract][Full Text] [Related]
57. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
58. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions.
Aatsinki SM; Buler M; Salomäki H; Koulu M; Pavek P; Hakkola J
Br J Pharmacol; 2014 May; 171(9):2351-63. PubMed ID: 24428821
[TBL] [Abstract][Full Text] [Related]
59. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
[TBL] [Abstract][Full Text] [Related]
60. CCAAT/enhancer binding protein-beta is a transcriptional regulator of peroxisome-proliferator-activated receptor-gamma coactivator-1alpha in the regenerating liver.
Wang H; Peiris TH; Mowery A; Le Lay J; Gao Y; Greenbaum LE
Mol Endocrinol; 2008 Jul; 22(7):1596-605. PubMed ID: 18467525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
